Lupus Nephritis: Navigating Therapeutic Possibilities to Optimize Outcomes This activity is supported by an educational grant from Genentech, a member of the Roche Group.

The authors study how apolipoprotein L1 variants impact inflammation and lipid accumulation in macrophages. The findings will be useful for researchers investigating macrophage metabolism and ...

Keywords: lupus nephritis, platelet to lymphocyte ratio, neutrophil to lymphocyte ratio, monocyte to lymphocyte ratio, prognosis, retrospective cohort study Citation: Qi W, Zhu R, Bai X, Luo P and Luo ...

The U.S. Food and Drug Administration has approved GSK's autoinjector of Benlysta (belimumab) for subcutaneous injection in patients ≥5 years of age with active lupus nephritis who are receiving ...

MONDAY, June 30, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved an autoinjector of Benlysta (belimumab) for subcutaneous injection in patients ≥5 years of age with ...

FDA Approves Benlysta Autoinjector for Pediatric Patients With Active Lupus Nephritis By Lori Solomon HealthDay ReporterMONDAY, June 30, 2025 (HealthDay News) -- The U.S. Food and Drug ...